Clique no nome do convidado e confira o minicurrículo:
Adrian Raine is the Richard Perry University Professor of Criminology, Psychiatry, and Psychology at the University of Pennsylvania. His research focuses on the etiology and prevention of antisocial, criminal, and psychopathic behavior in children and adults. His latest book, The Anatomy of Violence (2013, Pantheon and Penguin), reviews the brain basis to violence. He is past-President of the Academy of Experimental Criminology, and received an honorary degree from the University of York (UK) in 2015.
Professor Andrew John Lees, MD FRCP, FMedSci
Professor of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square and Emeritus Director, Reta Lila Weston Institute of Neurological Studies, University College London, Institute of Neurology
Born on Merseyside, Andrew Lees qualified in medicine at the Royal London Hospital Medical College in 1970. His neurological training was at University College London Hospitals and the National Hospital for Neurology and Neurosurgery, Queen Square. He also spent time at L’Hopital Salpetriere, Paris.
At the age of thirty-two he was appointed to the consultant staff at the National Hospitals, The Middlesex, and Whittington Hospitals and in 1987 was elected a Fellow of the Royal College of Physicians. He was later appointed Professor of Neurology at the National Hospital for Neurology and Neurosurgery, Queen Square and was Director of the Reta Lila Weston Institute for Neurological Studies (1998-2012). He was Clinical Director of the Queen Square Brain Bank for Neurological Disorders (1985-2012) and Director of the Sara Koe PSP Research Centre (2002-2012).
He is a Visiting Professor at the University of Liverpool and has close collaborations with a number of Brazilian universities. For his contributions to Brazilian neurology he was elected an overseas member of the Academia Nacional de Medicina and the Academia Brasileira de Neurologica. He was elected as a Council member of the Academy of Medical Sciences 2012- 2015.
Andrew has achieved international recognition for his work on Parkinson’s disease and abnormal movement disorders. He is an original member of the Highly Cited Researchers ISI Database. Founder member of the international Movement Disorder Society, he was elected President (2004-2006) and co-edited the Movement Disorders Journal between 1995 and 2003. In 2006, he was awarded the Movement Disorders Research Award by the American Academy of Neurology. In recent years he has delivered the Gowers Memorial Lecture at the National Hospital, The Inaugural Lord Brain Memorial Lecture at Barts and the Royal London Hospitals and David Marsden Memorial Lecture at the European Federation of Neurological Societies. He was the recipient of Stanley Fahn Lectureship Award, MDS Dublin 2012, and has been awarded the German Society of Neurology’s 2012 Dingebauer Prize for outstanding scientific attainment in the field of Parkinson‘s disease and Neurodegenerative Disorders.
In 2014, Andrew received the prestigious Jay Van Andel award for outstanding research in Parkinson’s disease. Based in Grand Rapids Michigan, the Van Andel Institute is an independent research organisation dedicated to preserving, enhancing and expanding the frontiers of medical science.
In 2015 he became the recipient of the Association of British Neurologists Medal, awarded annually in recognition of outstanding contributions by British and Irish neurologists to the science and practice of neurology.
Arthur Kramer is the Director of the Center for Cognitive and Brain Health and professor of Psychology at Northeastern University in Boston. He previously served as Senior Vice Provost for Research and Graduate Education at Northeastern University. He also served as the Director of the Beckman Institute for Advanced Science & Technology and the Swanlund Chair and Professor of Psychology and Neuroscience at the University of Illinois. He received his Ph.D. in Cognitive/Experimental Psychology from the University of Illinois. Professor Kramer’s research projects include topics in Aging, Cognitive Psychology, Cognitive Neuroscience, and Human Factors. A major focus of his labs recent research is the understanding and enhancement of cognitive and neural plasticity across the lifespan. He is a former Associate Editor of Perception and Psychophysics and is currently a member of six editorial boards. Professor Kramer is also a fellow of the American Psychological Association, American Psychological Society, a former member of the executive committee of the International Society of Attention and Performance, and a recipient of a NIH Ten Year MERIT Award. He has recently served on the Presidents Council of Advisors on Science & Technology (PCAST), the National Academy of Medicine’s (NAM) committee on Cognitive Aging, the Chair of the National Academy of Sciences (NAS) workshop on Understanding Pathways to Successful Aging: Behavioral and Social Factors Related to Alzheimer’s Disease, the Global Council on Brain Health, and a multitude of other national and international committees. Professor Kramer’s research has been featured in a long list of print, radio and electronic media including the New York Times, Wall Street Journal, Washington Post, Huffingtion Post, Chicago Tribune, CBS Evening News, Today Show, National Public Radio and Saturday Night Live.
Bradley Peterson, MD, is the Director of the Institute for the Developing Mind at Children’s Hospital Los Angeles. He is also Vice Chair for Research and Director of the Division of Child and Adolescent Psychiatry in the Department of Psychiatry at the University of Southern California. His research involves the development and use of neuroimaging technologies to identify the brain bases of psychiatric disorders and the mechanisms of therapeutic response. He is also trained in adult and child psychoanalysis. Dr. Peterson previously served as Director of Neuroimaging at the Yale Child Study Center, and as founding director of the MRI research program, Director of the Division of Child Psychiatry, and Director of the Center for Developmental Neuropsychiatry at Columbia University. He is the author of more than 300 peer-reviewed publications.
Dan J. Stein is Professor and Chair of the Dept of Psychiatry and Mental Health at the University of Cape Town and Director of the South African Medical Research Council’s Unit on Risk & Resilience in Mental Disorders. Dan’s training includes doctoral degrees in clinical neuroscience and in philosophy, and a post-doctoral fellowship in psychopharmacology. He is a clinician-scientist whose work has long focused on anxiety and related disorders, including obsessive-compulsive spectrum conditions and posttraumatic stress disorder. He has also mentored research of particular relevance to South Africa and Africa, including on neuroHIV and substance use disorders.
Howard J Federoff, M.D., Ph.D., has served as a physician executive, entrepreneur, inventor, clinician and scientist. He is the former CEO of the UCI Health System and Vice Chancellor for Health Affairs after previously serving as the Dean of the School of Medicine. Previously, he was EVP Health Sciences/Executive Dean at Georgetown University. A clinical and research leader and an investigator in gene therapy and neurological disorders, his research led to a new gene therapy trial in Parkinson’s disease, and in predicting the onset of Alzheimer’s disease. He has published many peer-reviewed and invited articles, holds a number of patents and serves on the editorial boards for several journals. He chaired the NIH Recombinant DNA Advisory Committee and the Gene Therapy Resource Program for NHLBI and chaired the Association of Academic Health Centers Board. He is an elected Fellow of the American Association for the Advancement of Science and the National Academy of Inventors.
Dr. Federoff co-founded several biotechnology companies including MedGenesis Therapeutix, a platform company using convection enhanced technology to deliver biologics to the brain of patients with Parkinson’s disease.
Dr. Federoff received his MS, PhD and MD from the Albert Einstein College of Medicine, completed his internship, residency and fellowships at the Massachusetts General Hospital, Harvard Medical School.
Professor Mark Solms is Director of Neuropsychology at the University of Cape Town and Groote Schuur Hospital. He is the recipient of numerous prizes and honours. He has published 350 articles in neuroscientific and psychoanalytic journals and has authored eight books. The Brain and the Inner World was translated into 13 languages. His collected papers were published recently as The Feeling Brain. He is the editor and translator of the forthcoming Revised Standard Edition of the Complete Psychological Works of Sigmund Freud (24 vols) and Complete Neuroscientific Works of Sigmund Freud (4 vols). Currently his main scientific focus is the brain mechanisms of consciousness and the implications of these mechanisms for the understanding and treatment of psychopathology. See Solms (2013) ‘The conscious id’ Neuropsychoananalysis; Solms (2017) ‘What is the unconscious and where is it located in the brain? Annals of the NY Academy of Sciences; Solms & Friston (in press) ‘How and why consciousness arises’ J Consciousness Studies.
Szyf is a professor of pharmacology and held a Glaxo Smith Kline and James McGill Chair in Pharmacology at McGill University in Montreal Canada and is a fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences. Szyf has pioneered research in DNA methylation for the last three decades and his interests span a broad spectrum from basic mechanisms to cancer diagnostics and therapeutics, as well as behavior, chronic pain and addiction. Szyf pioneered epigenetic pharmacology in cancer and as well as the field of behavioral epigenetics. Szyf studies provide a molecular link between environment and genes and between nurture and nature that had a wide impact on the social sciences and psychiatry.
Dr. Robert C. Malenka is the Pritzker Professor of Psychiatry and Deputy Director of the Wu Tsai Neurosciences Institute at Stanford University. He is an elected member of the United States’ National Academy of Sciences and the National Academy of Medicine and has been the recipient of numerous awards including the Society for Neuroscience Julius Axelrod Prize (2016). He is co-author of the textbook Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (McGraw Hill, 3rd edition, 2015). His many years of investigation have generated >270 papers that established some of the critical molecular mechanisms underlying synaptic plasticity and the circuit mechanisms by which neuromodulators influence many forms of adaptive and pathological motivated behaviors. His laboratory continues to conduct cutting edge research on the synaptic and circuit dysfunctions that contribute to brain disorders including addiction, autism, and depression.
Dr. Stahl iss professor at the University of California at San Diego and Honorary Fellow in Psychiatry at the University of Cambridge, editor-in-chief of CNS Spectrums and author of over 500 articles and chapters, and more than 1600 scientific presentations and abstracts, and 52 textbooks including the best selling Stahl’s Essential Psychopharmacology, now in its fourth edition and the best selling and award winning clinical manual, Essential Psychopharmacology Prescriber’s Guide, now in its sixth edition. His books have won the British Medical Association’s Book of the Year Award and recently, first prize for best digital medical book. Recently, Dr. Stahl has published his first novel, Shell Shock , a thriller that recounts the history of PTSD (post traumatic stress disorder). Dr. Stahl has been awarded the International College of Neuropsychopharmacology (CINP) Lundbeck Foundation Award in Education, the A.E. Bennett Award of the Society of Biological Psychiatry, the APA/San Diego Psychiatric Society Education Award, the UCSD Psychiatry Residency Teaching Award, has been cited as both one of “America’s Top Psychiatrists” and one of the “Best Doctors in America” and was honored with the Distinguished Psychiatrist Award of the APA and gave the Distinguished Psychiatrist Lecturer for 2013 and later the 2016 David Mrazek Award Winner of the American Psychiatric Association and gave the Mrazek Pharmacogenomics Memorial Lecture at the 2016 APA meeting.
Steven E. Hyman is director of the Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard, a core member of the Broad, and Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. From 2001 to 2011, Hyman served as provost of Harvard University, the university’s chief academic officer. As provost, he had a special focus on establishment of collaborative initiatives in the sciences and engineering spanning multiple disciplines and institutions. From 1996 to 2001, he served as director of the U.S. National Institute of Mental Health (NIMH), where he emphasized investment in neuroscience and emerging genetic technologies and initiated a series of large practical clinical trials that were forerunners of comparative efficacy studies. Hyman is president of the American College of Neuropsychopharmacology (2018), past president of the Society for Neuroscience (2015), and founding president of the International Neuroethics Society (2008-2014), and he previously served as editor of the Annual Review of Neuroscience (2002-2016). He is a member of the U.S. National Academy of Medicine where he serves on the council. He chairs the Forum on Neuroscience and Nervous System Disorders of the National Academies of Sciences, Engineering, and Medicine (NASEM), which brings together industry, government, academia, patient groups, and foundations, and he serves on the governing board of the National Research Council, the operating arm of NASEM. Hyman is a fellow of the American Academy of Arts and Sciences and the American Association for the Advancement of Science, and he is a Distinguished Life Fellow of the American Psychiatric Association. In 2016, he was awarded the Rhoda and Bernard Sarnat International Prize in Mental Health by the National Academy of Medicine. Hyman received his B.A. summa cum laude from Yale College, an M.A. from the University of Cambridge, which he attended as a Mellon fellow studying history and philosophy of science, and an M.D. cum laude from Harvard Medical School.
Professor of Psychiatry and Psychotherapy University of Freiburg, Germany; Head of the independent Division of Interventional Biological Psychiatry • Professor of Psychiatry and Mental Hygiene (part time), The Johns Hopkins University School of Medicine • Professor of Psychiatry, University of Florida, Gainesville, FL Professional Experience: Dr. Schlaepfer received his medical training at the University of Bern, Switzerland. He completed internship and residency training at the University Hospital Bern and the Johns Hopkins Hospital. Before assuming his current position as division head in Freiburg, he completed a Fellowship in Psychiatric Neuroimaging at the Johns Hopkins University and directed the Division of Psychiatric Neuroimaging at the University Hospital Bern, Switzerland. In 2003 be was elected Vice Chair of the Department of Psychiatry and Psychotherapy and Professor of Psychiatry, University Hospital Bonn, Germany. From 2006 to 2014 he acted as Dean of Medical Education of this University.
ir ao brain
Conheça os 5 motivos para participar do evento:
Szyf is a professor of pharmacology and held a Glaxo Smith Kline and James McGill Chair in Pharmacology at McGill University in Montreal Canada and is a fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences. Szyf has pioneered research in DNA methylation for the last thre...Saiba mais
Dr. Stahl iss professor at the University of California at San Diego and Honorary Fellow in Psychiatry at the University of Cambridge, editor-in-chief of CNS Spectrums and author of over 500 articles and chapters, and more than 1600 scientific presentations and abstracts, and 52 textbooks including ...Saiba mais
Professor of Psychiatry and Psychotherapy University of Freiburg, Germany; Head of the independent Division of Interventional Biological Psychiatry • Professor of Psychiatry and Mental Hygiene (part time), The Johns Hopkins University School of Medicine • Professor of Psychiatry, University of Flori...Saiba mais
Um dos maiores e mais modernos espaços para eventos do Brasil. Com padrão mundial de versatilidade, sustentabilidade e conforto, as tecnologias e dimensões do CICB proporcionam infinitas possibilidades.
Capaz de receber mais de 10.000 pessoas, o CICB foi projetado para oferecer entradas independentes e total isolamento acústico. O Centro também conta com estacionamento para 1.600 carros, sendo 1.000 em área coberta, entradas independentes para as docas e 6 geradores próprios e automatizados (de 625kvas cada proporcionando 3.750kvas) dando total autonomia ao local.
Setor de Clubes Esportivo Sul | Trecho 02, Conj. 63, Lote 50 | Brasília/DF, 70200-002, Brasil